BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhu SG, Li HB, Dai TX, Li H, Wang GY. Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report. World J Clin Cases 2022; 10(27): 9743-9749 [PMID: 36186195 DOI: 10.12998/wjcc.v10.i27.9743]
URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9743.htm
Number Citing Articles
Feng Xian, Dacheng Ren, Jun Bie, Guohui Xu. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysisFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1119168